Home › Companies › BICYCLE THERAPEUTICS PLC › 2025-2026
At BICYCLE THERAPEUTICS PLC's shareholder meeting held June 17, 2026, in the 2025-2026 proxy season, 92 asset managers reported how they voted in their SEC Form N-PX filings, covering 279 separate fund positions. Their filings are grouped here into 9 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — TO APPROVE, ON ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS, AS DISCLOSED… — FOR was 98% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: BICYCLE THERAPEUTICS PLC's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 18, 2026.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and BICYCLE THERAPEUTICS PLC’s Form 8-K, filed June 18, 2026 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of June 17, 2026: 9 items on BICYCLE THERAPEUTICS PLC’s Form 8-K, filed June 18, 2026: 9 without a stated outcome.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore BICYCLE THERAPEUTICS PLC in the interactive database Compare manager voting policies
These tallies are BICYCLE THERAPEUTICS PLC’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 18, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| 1. To re-elect as a director Felix Baker | 46,171,302 | 3,364,113 | 161,493 | -- | -- | 93% | Not verified | — |
| 2. To re-elect as a director Hervé Hoppenot | 49,284,459 | 250,669 | 161,780 | -- | -- | 99.4% | Not verified | — |
| 3. To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's definitive proxy statement | 48,748,743 | 785,032 | 163,133 | -- | -- | 98% | Not verified | — |
| 4. To ratify the appointment of PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as the Company's independent registered public accounting firm for the year ending December 31, 2026 | 49,445,128 | 232,627 | 19,153 | -- | -- | 99.5% | Not verified | — |
| 5. To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as the Company's U.K | 49,441,337 | 235,008 | 20,563 | -- | -- | 99.5% | Not verified | — |
| 6. To authorize the Audit Committee of the Company's Board of Directors to determine the Company's U.K | 49,493,240 | 47,269 | 156,399 | -- | -- | 99.9% | Not verified | — |
| 7. To receive and adopt the Company's U.K | 49,138,590 | 553,781 | 4,537 | -- | -- | 99% | Not verified | — |
| 8. To approve the directors' remuneration report for the year ended December 31, 2025, which report is set forth in the Company's definitive proxy statement (excluding the directors' remuneration policy) | 48,741,517 | 792,394 | 162,997 | -- | -- | 98% | Not verified | — |
| 9. To approve the directors' remuneration policy, which policy is set forth in the Company's definitive proxy statement, and which will take effect immediately after the end of the AGM | 48,238,031 | 1,293,722 | 165,155 | -- | -- | 97% | Not verified | — |
Source: BICYCLE THERAPEUTICS PLC, Form 8-K, filed with the SEC on June 18, 2026 — read the filing on EDGAR.
Each item below shows how the 92 asset managers that disclosed a BICYCLE THERAPEUTICS PLC vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of BICYCLE THERAPEUTICS PLC’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 2 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
Description as filed by funds: To re-elect as a director Felix Baker, who retires in accordance with the Articles of Association.
BICYCLE THERAPEUTICS PLC’s own tally for this item (“1. To re-elect as a director Felix Baker”): 46,171,302 for, 3,364,113 against, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 17 asset managers below reported 953,617 for, 1,014,600 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 0 | 691,267 | 0 | 0 | Against |
| Principal | 518,200 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 265,973 | 0 | 0 | 0 | For |
| BlackRock | 0 | 244,863 | 0 | 0 | Against |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 45,500 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 40,249 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 34,866 | 0 | 0 | 0 | For |
| Voya | 0 | 30,052 | 0 | 0 | Against |
| John Hancock | 0 | 25,602 | 0 | 0 | Against |
| Fidelity | 25,129 | 0 | 0 | 0 | For |
| Equitable | 0 | 20,819 | 0 | 0 | Against |
| STEWARD FUNDS, INC. | 11,209 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 6,102 | 0 | 0 | 0 | For |
| Invesco | 3,609 | 0 | 0 | 0 | For |
| State Street | 0 | 1,997 | 0 | 0 | Against |
| ProShares | 1,980 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 800 | 0 | 0 | 0 | For |
Combines 3 wordings of this item as funds reported it.
99.4% Majority: yes · of votes cast
Description as filed by funds: To re-elect as a director Herve Hoppenot, who retires in accordance with the Articles of Association.
BICYCLE THERAPEUTICS PLC’s own tally for this item (“2. To re-elect as a director Hervé Hoppenot”): 49,284,459 for, 250,669 against, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 17 asset managers below reported 1,968,217 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 691,267 | 0 | 0 | 0 | For |
| Principal | 518,200 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 265,973 | 0 | 0 | 0 | For |
| BlackRock | 244,863 | 0 | 0 | 0 | For |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 45,500 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 40,249 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 34,866 | 0 | 0 | 0 | For |
| Voya | 30,052 | 0 | 0 | 0 | For |
| John Hancock | 25,602 | 0 | 0 | 0 | For |
| Fidelity | 25,129 | 0 | 0 | 0 | For |
| Equitable | 20,819 | 0 | 0 | 0 | For |
| STEWARD FUNDS, INC. | 11,209 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 6,102 | 0 | 0 | 0 | For |
| Invesco | 3,609 | 0 | 0 | 0 | For |
| State Street | 1,997 | 0 | 0 | 0 | For |
| ProShares | 1,980 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 800 | 0 | 0 | 0 | For |
99% Majority: yes · of votes cast
Description as filed by funds: To receive and adopt our U.K. statutory annual accounts and reports for the year ended December 31, 2025 (the "2025 U.K. Annual Report").
BICYCLE THERAPEUTICS PLC’s own tally for this item (“7. To receive and adopt the Company's U.K”): 49,138,590 for, 553,781 against, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 17 asset managers below reported 1,968,217 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 691,267 | 0 | 0 | 0 | For |
| Principal | 518,200 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 265,973 | 0 | 0 | 0 | For |
| BlackRock | 244,863 | 0 | 0 | 0 | For |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 45,500 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 40,249 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 34,866 | 0 | 0 | 0 | For |
| Voya | 30,052 | 0 | 0 | 0 | For |
| John Hancock | 25,602 | 0 | 0 | 0 | For |
| Fidelity | 25,129 | 0 | 0 | 0 | For |
| Equitable | 20,819 | 0 | 0 | 0 | For |
| STEWARD FUNDS, INC. | 11,209 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 6,102 | 0 | 0 | 0 | For |
| Invesco | 3,609 | 0 | 0 | 0 | For |
| State Street | 1,997 | 0 | 0 | 0 | For |
| ProShares | 1,980 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 800 | 0 | 0 | 0 | For |
Combines 5 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: TO APPROVE, ON ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE PROXY STATEMENT.
BICYCLE THERAPEUTICS PLC’s own tally for this item (“3. To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's definitive proxy statement”): 48,748,743 for, 785,032 against, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 691,267 | 0 | 0 | 0 | For |
| Principal | 518,200 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 265,973 | 0 | 0 | 0 | For |
| BlackRock | 244,863 | 0 | 0 | 0 | For |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 45,500 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 40,249 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 34,866 | 0 | 0 | 0 | For |
| Voya | 30,052 | 0 | 0 | 0 | For |
| John Hancock | 25,602 | 0 | 0 | 0 | For |
| Fidelity | 25,129 | 0 | 0 | 0 | For |
| Equitable | 20,819 | 0 | 0 | 0 | For |
| STEWARD FUNDS, INC. | 11,209 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 6,102 | 0 | 0 | 0 | For |
| Invesco | 3,609 | 0 | 0 | 0 | For |
| State Street | 1,997 | 0 | 0 | 0 | For |
| ProShares | 1,980 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 800 | 0 | 0 | 0 | For |
Fund voting reports, all 17 managers: 1,968,217 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 10,885,357 | 0 | 0 | 0 | For |
| FCPM III SERVICES B.V. | 3,468,430 | 0 | 0 | 0 | For |
| ARMISTICE CAPITAL, LLC | 1,565,112 | 0 | 0 | 0 | For |
| Siren, L.L.C. | 1,560,882 | 0 | 0 | 0 | For |
| T. Rowe Price | 917,413 | 0 | 0 | 0 | For |
| ACADIAN ASSET MANAGEMENT LLC | 906,444 | 0 | 0 | 0 | For |
| PRINCIPAL GLOBAL INVESTORS | 740,054 | 0 | 0 | 0 | For |
| BESSEMER INVESTMENT MANAGEMENT LLC | 531,946 | 0 | 0 | 0 | For |
| Renaissance | 320,181 | 0 | 0 | 0 | For |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 247,618 | 0 | 0 | 0 | For |
| Rangeley Capital, LLC | 0 | 221,313 | 0 | 0 | Against |
| MOORE CAPITAL MANAGEMENT, LP | 196,188 | 0 | 0 | 0 | For |
| PLATINUM INVESTMENT MANAGEMENT LTD | 184,603 | 0 | 0 | 0 | For |
| Eversept Partners, LP | 179,452 | 0 | 0 | 0 | For |
| Peapod Lane Capital LLC | 135,320 | 0 | 0 | 0 | For |
| Two Sigma | 129,513 | 0 | 0 | 0 | For |
| Citadel | 127,866 | 0 | 0 | 0 | For |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 127,589 | 0 | 0 | 0 | For |
| PINNACLE ASSOCIATES LTD | 92,023 | 0 | 0 | 0 | For |
| DAFNA Capital Management LLC | 64,492 | 0 | 0 | 0 | For |
| Point72 | 64,386 | 0 | 0 | 0 | For |
| Maryland State Retirement & Pension System | 58,964 | 0 | 0 | 0 | For |
| BlackRock | 35,006 | 0 | 0 | 0 | For |
| Allianz | 34,100 | 0 | 0 | 0 | For |
| Voya | 30,052 | 0 | 0 | 0 | For |
Institutional-manager reports, all 78 managers: 22,897,610 for, 221,313 against, 24,773 not voted. Showing the 25 largest; every one is in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: To approve our directors' remuneration report for the year ended December 31, 2025, which is set forth as Annex A to the proxy statement (excluding the directors' remuneration policy set out on pages A-3 to A-22 of the directors' remuneration report and referenced in Proposal 9).
BICYCLE THERAPEUTICS PLC’s own tally for this item (“8. To approve the directors' remuneration report for the year ended December 31, 2025, which report is set forth in the Company's definitive proxy statement (excluding the directors' remuneration policy)”): 48,741,517 for, 792,394 against, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 691,267 | 0 | 0 | 0 | For |
| Principal | 518,200 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 265,973 | 0 | 0 | 0 | For |
| BlackRock | 244,863 | 0 | 0 | 0 | For |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 45,500 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 40,249 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 34,866 | 0 | 0 | 0 | For |
| Voya | 30,052 | 0 | 0 | 0 | For |
| John Hancock | 25,602 | 0 | 0 | 0 | For |
| Fidelity | 25,129 | 0 | 0 | 0 | For |
| Equitable | 20,819 | 0 | 0 | 0 | For |
| STEWARD FUNDS, INC. | 11,209 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 6,102 | 0 | 0 | 0 | For |
| Invesco | 3,609 | 0 | 0 | 0 | For |
| State Street | 1,997 | 0 | 0 | 0 | For |
| ProShares | 1,980 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 800 | 0 | 0 | 0 | For |
Fund voting reports, all 17 managers: 1,968,217 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Siren, L.L.C. | 1,560,882 | 0 | 0 | 0 | For |
| BlackRock | 35,006 | 0 | 0 | 0 | For |
| Vident Advisory, LLC | 269 | 0 | 0 | 0 | For |
Institutional-manager reports, all 3 managers: 1,596,157 for.
100% Fund and manager reports combined; may count the same shares twice · no official result
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 691,267 | 0 | 0 | 0 | For |
| Principal | 518,200 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 265,973 | 0 | 0 | 0 | For |
| BlackRock | 244,863 | 0 | 0 | 0 | For |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 45,500 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 40,249 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 34,866 | 0 | 0 | 0 | For |
| Voya | 30,052 | 0 | 0 | 0 | For |
| John Hancock | 25,602 | 0 | 0 | 0 | For |
| Fidelity | 25,129 | 0 | 0 | 0 | For |
| Equitable | 20,819 | 0 | 0 | 0 | For |
| STEWARD FUNDS, INC. | 11,209 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 6,102 | 0 | 0 | 0 | For |
| Invesco | 3,609 | 0 | 0 | 0 | For |
| State Street | 1,997 | 0 | 0 | 0 | For |
| ProShares | 1,980 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 800 | 0 | 0 | 0 | For |
Fund voting reports, all 17 managers: 1,968,217 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 35,006 | 0 | 0 | 0 | For |
| Vident Advisory, LLC | 269 | 0 | 0 | 0 | For |
Institutional-manager reports, all 2 managers: 35,275 for.
99.9% Majority: yes · of votes cast
Description as filed by funds: To authorize the Audit Committee to determine our U.K. statutory auditors' remuneration for the year ending December 31, 2026.
BICYCLE THERAPEUTICS PLC’s own tally for this item (“6. To authorize the Audit Committee of the Company's Board of Directors to determine the Company's U.K”): 49,493,240 for, 47,269 against, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 17 asset managers below reported 1,968,217 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 691,267 | 0 | 0 | 0 | For |
| Principal | 518,200 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 265,973 | 0 | 0 | 0 | For |
| BlackRock | 244,863 | 0 | 0 | 0 | For |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 45,500 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 40,249 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 34,866 | 0 | 0 | 0 | For |
| Voya | 30,052 | 0 | 0 | 0 | For |
| John Hancock | 25,602 | 0 | 0 | 0 | For |
| Fidelity | 25,129 | 0 | 0 | 0 | For |
| Equitable | 20,819 | 0 | 0 | 0 | For |
| STEWARD FUNDS, INC. | 11,209 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 6,102 | 0 | 0 | 0 | For |
| Invesco | 3,609 | 0 | 0 | 0 | For |
| State Street | 1,997 | 0 | 0 | 0 | For |
| ProShares | 1,980 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 800 | 0 | 0 | 0 | For |
100% of fund votes cast · no official result
Description as filed by funds: To ratify the appointment of PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as our independent registered public accounting firm for the year ending December 31, 2026.
The 17 asset managers below reported 1,968,217 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 691,267 | 0 | 0 | 0 | For |
| Principal | 518,200 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 265,973 | 0 | 0 | 0 | For |
| BlackRock | 244,863 | 0 | 0 | 0 | For |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 45,500 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 40,249 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 34,866 | 0 | 0 | 0 | For |
| Voya | 30,052 | 0 | 0 | 0 | For |
| John Hancock | 25,602 | 0 | 0 | 0 | For |
| Fidelity | 25,129 | 0 | 0 | 0 | For |
| Equitable | 20,819 | 0 | 0 | 0 | For |
| STEWARD FUNDS, INC. | 11,209 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 6,102 | 0 | 0 | 0 | For |
| Invesco | 3,609 | 0 | 0 | 0 | For |
| State Street | 1,997 | 0 | 0 | 0 | For |
| ProShares | 1,980 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 800 | 0 | 0 | 0 | For |
99.5% Majority: yes · of votes cast
Description as filed by funds: To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as our U.K. statutory auditors, to hold office until the conclusion of the next annual general meeting of shareholders.
BICYCLE THERAPEUTICS PLC’s own tally for this item (“5. To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as the Company's U.K”): 49,441,337 for, 235,008 against, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 17 asset managers below reported 1,968,217 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 691,267 | 0 | 0 | 0 | For |
| Principal | 518,200 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 265,973 | 0 | 0 | 0 | For |
| BlackRock | 244,863 | 0 | 0 | 0 | For |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 45,500 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 40,249 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 34,866 | 0 | 0 | 0 | For |
| Voya | 30,052 | 0 | 0 | 0 | For |
| John Hancock | 25,602 | 0 | 0 | 0 | For |
| Fidelity | 25,129 | 0 | 0 | 0 | For |
| Equitable | 20,819 | 0 | 0 | 0 | For |
| STEWARD FUNDS, INC. | 11,209 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 6,102 | 0 | 0 | 0 | For |
| Invesco | 3,609 | 0 | 0 | 0 | For |
| State Street | 1,997 | 0 | 0 | 0 | For |
| ProShares | 1,980 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 800 | 0 | 0 | 0 | For |
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 69,707,026 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | T. Rowe Price | 0.99% |
| 2 | Principal | 0.74% |
| 3 | OLD WESTBURY FUNDS INC | 0.38% |
| 4 | BlackRock | 0.35% |
| 5 | PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 0.07% |
| 6 | ALPS ETF Trust | 0.06% |
| 7 | ETFis Series Trust I | 0.05% |
| 8 | Voya | 0.04% |
| 9 | John Hancock | 0.04% |
| 10 | Fidelity | 0.04% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BAKER BROS. ADVISORS LP | 15.62% |
| 2 | FCPM III SERVICES B.V. | 4.98% |
| 3 | ARMISTICE CAPITAL, LLC | 2.25% |
| 4 | Siren, L.L.C. | 2.24% |
| 5 | T. Rowe Price | 1.32% |
| 6 | ACADIAN ASSET MANAGEMENT LLC | 1.30% |
| 7 | PRINCIPAL GLOBAL INVESTORS | 1.06% |
| 8 | BESSEMER INVESTMENT MANAGEMENT LLC | 0.76% |
| 9 | Renaissance | 0.46% |
| 10 | SILVERCREST ASSET MANAGEMENT GROUP LLC | 0.36% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Armistice Capital, LLC | 4.87% | 13G |
| LONG FOCUS CAPITAL MANAGEMENT, LLC | 4.75% | 13G |
| Raymond Debbane | 2.24% | 13G |
| T. Rowe Price | 1.48% | 13F |
| Renaissance Technologies | 1.40% | 13F |
| Morgan Stanley | 0.67% | 13F |
| Citadel Advisors | 0.59% | 13F |
| Millennium Management | 0.41% | 13F |
| BlackRock | 0.40% | 13F |
| Two Sigma | 0.24% | 13F |
Percentages above are of 69,707,026 shares outstanding, as reported by BICYCLE THERAPEUTICS PLC on its Form 10-Q dated March 31, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from BICYCLE THERAPEUTICS PLC’s 10-Q dated March 31, 2026. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
BICYCLE THERAPEUTICS PLC proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
proxyvotesnow.com, “BICYCLE THERAPEUTICS (BCYC) 2026 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/bicycle-therapeutics-plc/2026 (version of November 8, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.